Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 217 clinical trials
Antidepressant Discontinuation in Treatment Resistant Depression

treating treatment-resistant depression.

depressive symptoms
prozac
antidepressants
depressive disorder
  • 103 views
  • 04 Jun, 2022
  • 1 location
PCS in Severe Treatment Resistant Depression

This research study is designed to test if electrical stimulation of the surface of the brain in the frontal region will help treat depressive symptoms. Participants receive intermittent electrical stimulation to the brain, which involves surgically placing electric leads in between the tough fibrous membrane covering the surface of the …

  • 15 views
  • 08 Apr, 2023
  • 1 location
Psilocybin Versus Ketamine in Treatment-Resistant Depression (PSIKET_001)

The main goal is to compare the antidepressant effects of psilocybin and ketamine in patients with TRD versus the antidepressant inactive substance midazolam. The primary endpoint will be the antidepressant effect on the Montgomery- Asberg Depression Rating Scale (MADRS) 24 hours after treatment, the key secondary endpoints being the duration …

  • 11 views
  • 03 Jun, 2022
  • 1 location
Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression

This study will evaluate the efficacy and safety of NV-5138 in adults with TRD

  • 2 views
  • 07 Apr, 2022
A Biomarker-Guided, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With Treatment Resistant Depression (ENLIGHTEN)

This study will be conducted as a randomized, double-blind, placebo-controlled, multi-center Phase 2b study. Approximately 180 subjects with treatment resistant depression who meet all

  • 0 views
  • 21 Oct, 2022
  • 9 locations
  • 0 views
  • 09 Apr, 2023
  • 1 location
Precision Targeting of Propofol-induced Electroencephalographic Slow Waves: a Novel Phase I/2 Paradigm for Treatment-resistant Major Depressive Disorder

Our overall hypothesis is that sleep slow-wave potentiation by propofol is a therapeutic pathway for enhancing slow wave sleep and alleviating treatment-resistant depression (TRD).

  • 0 views
  • 14 Oct, 2022
  • 1 location
Accelerated TBS in Late Life Depression

This study is a single-arm, open-label, feasibility trial for the assessment of the clinical effects of a course of accelerated bilateral sequential theta burst stimulation (TBS) for late life depression (LLD). Over approximately 1 year, 30 outpatients at the Centre for Addiction and Mental Health (CAMH) meeting diagnostic criteria for …

  • 0 views
  • 26 Nov, 2021
  • 1 location
Establishing a Dose-response Relationship With Accelerated Transcranial Magnetic Stimulation

This study evaluates an accelerated schedule of theta-burst stimulation using a transcranial magnetic stimulation device for treatment-resistant depression. In a double-blind, randomized, sham

  • 7 views
  • 12 May, 2022
  • 1 location
Psilocybin in Depression Resistant to Standard Treatments

A single centre clinical trial to evaluate the feasibility, safety and efficacy of psilocybin, given under supportive conditions, in a randomised, blinded design in adult participants with treatment resistant major depressive disorder. The primary objective is to evaluate feasibility by measuring recruitment rates, dropout rates and by estimating the variance …

  • 29 views
  • 30 Jul, 2021
  • 1 location